Background: It is unknown whether renal pathology lesions in immunoglobulin A nephropathy (IgAN) correlate with renal outcomes over decades of follow-up. Methods: In 1130 patients of the original Validation Study of the Oxford Classification for IgA Nephropathy (VALIGA) cohort, we studied the relationship between the MEST score (mesangial hypercellularity, M; endocapillary hypercellularity, E; segmental glomerulosclerosis, S; tubular atrophy/interstitial fibrosis, T), crescents (C) and other histological lesions with both a combined renal endpoint [50% estimated glomerular filtration rate (eGFR) loss or kidney failure] and the rate of eGFR decline over a follow-up period extending to 35 years [median 7 years (interquartile range 4.1-10.8)]. Results: In this extended analysis, M1, S1 and T1-T2 lesions as well as the whole MEST score were independently related with the combined endpoint (P < 0.01), and there was no effect modification by age for these associations, suggesting that they may be valid in children and in adults as well. Only T lesions were associated with the rate of eGFR loss in the whole cohort, whereas C showed this association only in patients not treated with immunosuppression. In separate prognostic analyses, the whole set of pathology lesions provided a gain in discrimination power over the clinical variables alone, which was similar at 5 years (+2.0%) and for the whole follow-up (+1.8%). A similar benefit was observed for risk reclassification analyses (+2.7% and +2.4%). Conclusion: Long-term follow-up analyses of the VALIGA cohort showed that the independent relationship between kidney biopsy findings and the risk of progression towards kidney failure in IgAN remains unchanged across all age groups and decades after the renal biopsy.

Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update / Coppo, R.; D'Arrigo, G.; Tripepi, G.; Russo, M. L.; Roberts, I. S. D.; Bellur, S.; Cattran, D.; Cook, T. H.; Feehally, J.; Tesar, V.; Maixnerova, D.; Peruzzi, L.; Amore, A.; Lundberg, S.; Di Palma, A. M.; Gesualdo, L.; Emma, F.; Rollino, C.; Praga, M.; Biancone, L.; Pani, A.; Feriozzi, S.; Polci, R.; Barratt, J.; Del Vecchio, L.; Locatelli, F.; Pierucci, A.; Caliskan, Y.; Perkowska-Ptasinska, A.; Durlik, M.; Moggia, E.; Ballarin, J. C.; Wetzels, J. F. M.; Goumenos, D.; Papasotiriou, M.; Galesic, K.; Toric, L.; Papagianni, A.; Stangou, M.; Benozzi, L.; Cusinato, S.; Berg, U.; Topaloglu, R.; Maggio, M.; Ots-Rosenberg, M.; D'Amico, M.; Geddes, C.; Balafa, O.; Quaglia, M.; Cravero, R.; Cirami, C. L.; Fellstrom, B.; Floege, J.; Egido, J.; Mallamaci, F.; Zoccali, C.; Tesar, V.; Maixnerova, D.; Lundberg, S.; Gesualdo, L.; Emma, F.; Fuiano, L.; Beltrame, G.; Rollino, C.; Coppo, R.; Amore, A.; Camilla, R.; Peruzzi, L.; Praga, M.; Feriozzi, S.; Polci, R.; Segoloni, G.; Colla, L.; Pani, A.; Angioi, A.; Piras, L.; Feehally, J.; Cancarini, G.; Ravera, S.; Durlik, M.; Moggia, E.; Ballarin, J.; Di Giulio, S.; Pugliese, F.; Serriello, I.; Caliskan, Y.; Sever, M.; Kilicaslan, I.; Locatelli, F.; Del Vecchio, L.; Wetzels, J. F. M.; Peters, H.; Berg, U.; Carvalho, F.; Da Costa Ferreira, A. C.; Maggio, M.; Wiecek, A.; Ots-Rosenberg, M.; Magistroni, R.; Topaloglu, R.; Bilginer, Y.; D'Amico, M.; Stangou, M.; Giacchino, F.; Goumenos, D.; Papastirou, M.; Galesic, K.; Toric, L.; Geddes, C.; Siamopoulos, K.; Balafa, O.; Galliani, M.; Stratta, P.; Quaglia, M.; Bergia, R.; Cravero, R.; Salvadori, M.; Cirami, L.; Fellstrom, B.; Kloster Smerud, H.; Ferrario, F.; Stellato, T.; Egido, J.; Martin, C.; Floege, J.; Eitner, F.; Rauen, T.; Lupo, A.; Bernich, P.; Mene, P.; Morosetti, M.; Van Kooten, C.; Rabelink, T.; Reinders, M. E. J.; Boria Grinyo, J. M.; Cusinato, S.; Benozzi, L.; Savoldi, S.; Licata, C.; Mizerska-Wasiak, M.; Roszkowska-Blaim, M.; Martina, G.; Messuerotti, A.; Dal Canton, A.; Esposito, C.; Migotto, C.; Triolo, G.; Mariano, F.; Pozzi, C.; Boero, R.; Mazzucco, G.; Giannakakis, C.; Honsova, E.; Sundelin, B.; Di Palma, A. M.; Ferrario, F.; Gutierrez, E.; Asunis, A. M.; Barratt, J.; Tardanico, R.; Perkowska-Ptasinska, A.; Arce Terroba, J.; Fortunato, M.; Pantzaki, A.; Ozluk, Y.; Steenbergen, E.; Soderberg, M.; Riispere, Z.; Furci, L.; Orhan, D.; Kipgen, D.; Casartelli, D.; Galesic Ljubanovic, D.; Akiopoulou, H.; Bertoni, E.; Cannata Ortiz, P.; Karkoszka, H.; Groene, H. J.; Stoppacciaro, A.; Bajema, I.; Bruijn, J.; Fulladosa Oliveras, X.; Maldyk, J.; Ioachim, E.. - In: NEPHROLOGY DIALYSIS TRANSPLANTATION. - ISSN 0931-0509. - 35:6(2020), pp. 1002-1009. [10.1093/ndt/gfy302]

Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update

Magistroni R.
Membro del Collaboration Group
;
2020

Abstract

Background: It is unknown whether renal pathology lesions in immunoglobulin A nephropathy (IgAN) correlate with renal outcomes over decades of follow-up. Methods: In 1130 patients of the original Validation Study of the Oxford Classification for IgA Nephropathy (VALIGA) cohort, we studied the relationship between the MEST score (mesangial hypercellularity, M; endocapillary hypercellularity, E; segmental glomerulosclerosis, S; tubular atrophy/interstitial fibrosis, T), crescents (C) and other histological lesions with both a combined renal endpoint [50% estimated glomerular filtration rate (eGFR) loss or kidney failure] and the rate of eGFR decline over a follow-up period extending to 35 years [median 7 years (interquartile range 4.1-10.8)]. Results: In this extended analysis, M1, S1 and T1-T2 lesions as well as the whole MEST score were independently related with the combined endpoint (P < 0.01), and there was no effect modification by age for these associations, suggesting that they may be valid in children and in adults as well. Only T lesions were associated with the rate of eGFR loss in the whole cohort, whereas C showed this association only in patients not treated with immunosuppression. In separate prognostic analyses, the whole set of pathology lesions provided a gain in discrimination power over the clinical variables alone, which was similar at 5 years (+2.0%) and for the whole follow-up (+1.8%). A similar benefit was observed for risk reclassification analyses (+2.7% and +2.4%). Conclusion: Long-term follow-up analyses of the VALIGA cohort showed that the independent relationship between kidney biopsy findings and the risk of progression towards kidney failure in IgAN remains unchanged across all age groups and decades after the renal biopsy.
2020
35
6
1002
1009
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update / Coppo, R.; D'Arrigo, G.; Tripepi, G.; Russo, M. L.; Roberts, I. S. D.; Bellur, S.; Cattran, D.; Cook, T. H.; Feehally, J.; Tesar, V.; Maixnerova, D.; Peruzzi, L.; Amore, A.; Lundberg, S.; Di Palma, A. M.; Gesualdo, L.; Emma, F.; Rollino, C.; Praga, M.; Biancone, L.; Pani, A.; Feriozzi, S.; Polci, R.; Barratt, J.; Del Vecchio, L.; Locatelli, F.; Pierucci, A.; Caliskan, Y.; Perkowska-Ptasinska, A.; Durlik, M.; Moggia, E.; Ballarin, J. C.; Wetzels, J. F. M.; Goumenos, D.; Papasotiriou, M.; Galesic, K.; Toric, L.; Papagianni, A.; Stangou, M.; Benozzi, L.; Cusinato, S.; Berg, U.; Topaloglu, R.; Maggio, M.; Ots-Rosenberg, M.; D'Amico, M.; Geddes, C.; Balafa, O.; Quaglia, M.; Cravero, R.; Cirami, C. L.; Fellstrom, B.; Floege, J.; Egido, J.; Mallamaci, F.; Zoccali, C.; Tesar, V.; Maixnerova, D.; Lundberg, S.; Gesualdo, L.; Emma, F.; Fuiano, L.; Beltrame, G.; Rollino, C.; Coppo, R.; Amore, A.; Camilla, R.; Peruzzi, L.; Praga, M.; Feriozzi, S.; Polci, R.; Segoloni, G.; Colla, L.; Pani, A.; Angioi, A.; Piras, L.; Feehally, J.; Cancarini, G.; Ravera, S.; Durlik, M.; Moggia, E.; Ballarin, J.; Di Giulio, S.; Pugliese, F.; Serriello, I.; Caliskan, Y.; Sever, M.; Kilicaslan, I.; Locatelli, F.; Del Vecchio, L.; Wetzels, J. F. M.; Peters, H.; Berg, U.; Carvalho, F.; Da Costa Ferreira, A. C.; Maggio, M.; Wiecek, A.; Ots-Rosenberg, M.; Magistroni, R.; Topaloglu, R.; Bilginer, Y.; D'Amico, M.; Stangou, M.; Giacchino, F.; Goumenos, D.; Papastirou, M.; Galesic, K.; Toric, L.; Geddes, C.; Siamopoulos, K.; Balafa, O.; Galliani, M.; Stratta, P.; Quaglia, M.; Bergia, R.; Cravero, R.; Salvadori, M.; Cirami, L.; Fellstrom, B.; Kloster Smerud, H.; Ferrario, F.; Stellato, T.; Egido, J.; Martin, C.; Floege, J.; Eitner, F.; Rauen, T.; Lupo, A.; Bernich, P.; Mene, P.; Morosetti, M.; Van Kooten, C.; Rabelink, T.; Reinders, M. E. J.; Boria Grinyo, J. M.; Cusinato, S.; Benozzi, L.; Savoldi, S.; Licata, C.; Mizerska-Wasiak, M.; Roszkowska-Blaim, M.; Martina, G.; Messuerotti, A.; Dal Canton, A.; Esposito, C.; Migotto, C.; Triolo, G.; Mariano, F.; Pozzi, C.; Boero, R.; Mazzucco, G.; Giannakakis, C.; Honsova, E.; Sundelin, B.; Di Palma, A. M.; Ferrario, F.; Gutierrez, E.; Asunis, A. M.; Barratt, J.; Tardanico, R.; Perkowska-Ptasinska, A.; Arce Terroba, J.; Fortunato, M.; Pantzaki, A.; Ozluk, Y.; Steenbergen, E.; Soderberg, M.; Riispere, Z.; Furci, L.; Orhan, D.; Kipgen, D.; Casartelli, D.; Galesic Ljubanovic, D.; Akiopoulou, H.; Bertoni, E.; Cannata Ortiz, P.; Karkoszka, H.; Groene, H. J.; Stoppacciaro, A.; Bajema, I.; Bruijn, J.; Fulladosa Oliveras, X.; Maldyk, J.; Ioachim, E.. - In: NEPHROLOGY DIALYSIS TRANSPLANTATION. - ISSN 0931-0509. - 35:6(2020), pp. 1002-1009. [10.1093/ndt/gfy302]
Coppo, R.; D'Arrigo, G.; Tripepi, G.; Russo, M. L.; Roberts, I. S. D.; Bellur, S.; Cattran, D.; Cook, T. H.; Feehally, J.; Tesar, V.; Maixnerova, D.; ...espandi
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1255164
Citazioni
  • ???jsp.display-item.citation.pmc??? 33
  • Scopus 60
  • ???jsp.display-item.citation.isi??? 54
social impact